Search over 78,000 Information Industry Mergers & Acquisitions:
MindMed, will acquire HealthMode
Like HealthMode
Education

Finance

Healthcare

Consumer

Human Capital

Media & Marketing

Software

Online & Mobile

Managed Services & IT Consulting

Private Equity

Miscellaneous

Online & Mobile
E-Marketing & Search

Communications

SaaS & Cloud

Software
Consumer Software

Niche Software

Consumer
Miscellaneous

Mobile

Healthcare
Pharma IT

Health IT

Search Breadth
Narrower
Broader
By HealthMode
Healthcare

Software

Online & Mobile

Online & Mobile
SaaS & Cloud

Software
Niche Software

Healthcare
Pharma IT

By MindMed
Healthcare

Software

Online & Mobile

Online & Mobile
SaaS & Cloud

Software
Niche Software

Healthcare
Pharma IT

MindMed Competitor`s Deals
Healthcare

Consumer

Media & Marketing

Software

Online & Mobile

Private Equity

Online & Mobile
SaaS & Cloud

Software
Consumer Software

Niche Software

Consumer
Miscellaneous

Video Games

Software

Media & Marketing
Consumer Publishing

Healthcare
Miscellaneous

Pharma IT

Health IT

Consumer Health

Pharma Business Services

Healthcare Business Services

Search Breadth
Narrower
Broader
note: a single transaction may fall into multiple segments
view all transactions
All Segments
01/08/04 to 02/19/21
(869 results)
Transactions
Tombstones
Trends
Highlights
Overview
Geography
Company
Like HealthMode
- buyer to watch list
- seller to watch list
announced 2/19/2021 via PR Newswire
MindMed, will acquire HealthMode
synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer:
MindMed
(OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target:
HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 9/12/2018 via Forbes
Medopad, acquired Sherbit
synopsis: Medopad, a British health technology company that uses apps and wearables to monitor patient vital signs, has bought Sherbit, a rival startup in the US. Sherbit allows care teams to monitor patients through multiple apps and devices and effectively engage them with coaching, action plans, and preventative alerts.
buyer:
Medopad
Medopad provides enterprise mobile health solutions. Its product includes mobile health operating system, a patient data access platform that delivers patient information and clinical applications to doctors. The company offers mobile device management solutions. "
target:
Sherbit
Sherbit is a healthcare analytics company. Sherbit allows care teams to monitor patients through multiple apps and devices and effectively engage them with coaching, action plans, and preventative alerts.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 6/11/2020 via BNC Analysis
Milliman, Inc., acquired Healthio Inc.
synopsis: Brookfield-based and artificial intelligence startup HealthIO, which develops a platform for wearable, internet-connected devices to monitor a person’s health in between clinic visits, has been acquired by Milliman, a Seattle consulting firm.
buyer:
Milliman, Inc.
Milliman is among the world's largest providers of actuarial and related products and services. They provide consulting practices in employee benefits, healthcare, investment, life insurance and financial services, and property and casualty insurance. "
target:
Healthio Inc.
healthio combines the forces of IoT, Big Data and AI in healthcare to predict adverse events and progression of chronic conditions. healthio is about the DATA: establishing a longitudinal data pattern and combining it with historical data enables intelligence for early detection.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 7/10/2019 via PR Newswire
Waystar, acquired Digitize.AI, Inc.
synopsis: Waystar, a leading provider of revenue cycle technology, has acquired Digitize.AI, an artificial intelligence technology (AI) firm providing the healthcare industry with smarter prior authorizations. Digitize.AI offers AI enabled systems that help providers and health plans to maximize productivity and improve the member-patient experience.
buyer:
Waystar
Waystar provides next-generation, cloud-based technology that simplifies and unifies the healthcare revenue cycle. The Waystar platform removes friction in payment processes, streamlines workflows and improves financials for providers in every care setting. "
target:
Digitize.AI, Inc.
Digitize.AI is an artificial intelligence (AI) technology firm providing the healthcare industry with faster and smarter prior authorizations. Digitize.AI offers Lia and Mia, AI enabled systems that help providers and health plans to maximize productivity and improve the member-patient experience.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 7/29/2020 via Company Press Release
CIOX Health, acquired Medal, Inc.
synopsis: Ciox Health, a leading health technology company, today announced its acquisition of San Francisco-based biomedical Natural Language Processing (biomed-NLP) technology company, Medal, Inc., a leader in the application of AI techniques to the interrogation of unstructured medical record data.
buyer parent:
New Mountain Capital, LLC
buyer: CIOX Health
buyer: CIOX Health
Ciox Health facilitates and manages the movement of health information with the industry’s broadest provider network. They improve the management and exchange of health information by modernizing workflows, facilitating access to clinical data, & improving the accuracy & flow of health information. "
target:
Medal, Inc.
Medal, Inc. a leader in the application of AI techniques to the interrogation of unstructured medical record data. Medal’s software helps identify, contextualize, and interpret narrative-based medical notes, leading to the creation of research-grade data sets at scale.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 7/15/2020 via PR Newswire
Eversana, acquired HVH Precision Analytics
synopsis: EVERSANA™, the leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform. Previously owned by Havas Health & You and Perspecta, HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
buyer parent:
Water Street Healthcare Partners
buyer: Eversana
target: HVH Precision Analytics
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target parent:
Vivendi SA
target: HVH Precision Analytics
HVH Precision Analytics and its predictive analytics platform leverage analytic expertise originally honed to support military and U.S. intelligence community. HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 10/3/2019 via BNC Analysis
Abeo, Inc., acquired Trusted i10
synopsis: abeo, a leader in physician-focused billing and practice management solutions, has acquired Trusted i10. Trusted i10 has proven next generation technology that solves the issue of medical record data overload. Through technology, they process copious amounts of free text data and turn it into actionable information.
buyer parent:
Parthenon Capital Partners
buyer: Abeo, Inc.
buyer: Abeo, Inc.
abeo Management Corporation (abeo) serves as a leading source of revenue cycle management and practice management for hospital-based specialties, originating from deep-rooted experience within Anesthesiology. "
target:
Trusted i10
Trusted i10 has proven next generation technology that solves the issue created by modern electronic medical systems: medical record data overload. Through technology, they process copious amounts of free text data and turn it into actionable information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 4/17/2019 via PE Hub
EMV Capital Ltd, acquired Wanda Health
synopsis: EMV Capital, a London-based early-stage venture investor, has acquired Wanda Inc from NetScientific, a transatlantic healthcare IP commercialisation group. Wanda is a digital health company that offers advanced clinical decision support software powered by machine learning to improve and simplify life for people with serious health risks.
buyer:
EMV Capital Ltd
target: Wanda Health
EMV Capital (EMVC) is a London-based early-stage venture investor focused on B2B companies in the industrial high-tech, energy, circular economy, smart cities, transportation and healthcare sectors. EMVC’s investments cover a range of technologies, including AI, machine learning, IoT, and more. "
target parent:
NetScientific
target: Wanda Health
Wanda is a digital health company. Wanda offers advanced clinical decision support software powered by machine learning and real time patient data analysis to improve and simplify life for people with serious health risks. Wanda empowers clinically guided interventions to prevent rehospitalizations.
price ($mm)
$0.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 11/17/2017 via BNC Analysis
Roche Ltd, will acquire Viewics, Inc.
synopsis: Roche announced an agreement with Viewics, Inc., a privately held software company focused on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond, pioneering a new way in extracting, cleansing, transforming and augmenting data.
buyer:
Roche Ltd
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare. "
target:
Viewics, Inc.
California-based Viewics Inc. is a software company that focuses on laboratory business analytics. The Viewics solution allows for efficient integration of big data from a variety of IT systems in the laboratory and beyond.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 8/4/2020 via BusinessWire
GI Partners, acquired Clinical Ink
synopsis: Clinical Ink, a global clinical trial technology company, announced its acquisition by GI Partners, a leading private equity investment firm. Clinical Ink's service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
buyer:
GI Partners
target: Clinical Ink
GI Partners is a private investment firm based in San Francisco. The firm has raised over $20 billion in capital from leading institutional around the world to invest in private equity, real estate, and data infrastructure strategies. "
target parent:
NovaQuest
target: Clinical Ink
Clinical Ink is a global clinical technology company. Their service-first methodology and dedication to supporting a wide range of deployment options enable confident decisions, faster, and have driven meaningful industry adoption.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 5/15/2018 via Company Press Release
NovaQuest, acquired Clinical Ink
synopsis: Clinical Ink, the pioneering provider of eSource and next-generation ePRO/eCOA solutions for clinical development, announced that the private equity team at NovaQuest Capital Management has acquired a majority of the outstanding shares of the company from existing investors and provided a substantial infusion of additional growth capital.
buyer:
NovaQuest
NovaQuest Capital Management is a leading investor in life sciences and healthcare through their BioPharma and Private Equity strategies. NovaQuest Capital Management manages over $1.6 billion through two platforms: BioPharma and Private Equity. "
target:
Clinical Ink
Clinical Ink provides eSource solutions for the clinical trials industry. It offers SureSource, an electronic source solution that allows users to record comments, explanations, and validated source data on protocol specific eSource documents, as well as captures the data required by the protocol.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 11/6/2019 via BNC Analysis
Optum, acquired Vivify Health Inc.
synopsis: UnitedHealth subsidiary Optum acquired Texas-based remote patient monitoring (RPM) startup Vivify Health. Vivify equips payers and providers with a comprehensive RPM platform, complete with a suite of connected medical devices and mobile health apps.
buyer parent:
UnitedHealth Group
buyer: Optum
buyer: Optum
Optum is a health services and innovation company on a mission to help make the health system work better for everyone. They combine data and analytics with technology and expertise to power modern health care. "
target:
Vivify Health Inc.
Vivify equips payers and providers with a comprehensive RPM (Remote Patient Monitoring) platform, complete with a suite of connected medical devices and mobile health apps. Its platform has contributed to 76% fewer patient readmissions at University of Pittsburgh Medical Center (UPMC).
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 5/21/2018 via GlobeNewswire
FollowMyHealth, acquired HealthGrid
synopsis: Health IT vendor Allscripts has acquired HealthGrid through FollowMyHealth, a web based patient portal. HealthGrid gives health systems and providers a powerful enterprise patient engagement platform to connect patients anytime, anywhere, on any device.
buyer parent:
Allscripts
buyer: FollowMyHealth
buyer: FollowMyHealth
FollowMyHealth is a web based patient portal which allows patients to view and manage their healthcare information and connect with their providers from anywhere. FollowMyHealth is an innovator and leader in the movement toward patients taking a proactive role in managing their health and wellness. "
target:
HealthGrid
HealthGrid is shifting the patient experience paradigm and meeting patients where they are. By simplifying care throughout the continuum, HealthGrid gives health systems and providers a powerful enterprise patient engagement platform to connect patients anytime, anywhere, on any device.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 2/13/2018 via BusinessWire
Fitbit Inc., will acquire Twine Health
synopsis: Fitbit, Inc., the leading global wearables brand, announced that it will acquire Twine Health, an innovative, proven health coaching platform that empowers people to achieve better health outcomes and helps health systems, health plans and workplace health providers lower healthcare costs.
buyer:
Fitbit Inc.
(FIT:$1,550.22)
Fitbit helps people lead healthier, more active lives by empowering them with data, inspiration and guidance to reach their goals. As the leader in the Connected Health & Fitness category, Fitbit designs products and experiences that track everyday health and fitness. "
target:
Twine Health
Twine Health is an innovative, proven health coaching platform that empowers people to achieve better health outcomes and helps health systems, health plans and workplace health providers lower healthcare costs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 8/1/2016 via PR Newswire
CRF Health, acquired Entra Health
synopsis: CRF Health, the leading global provider of eCOA solutions for the life sciences industry, has acquired Entra Health, a global leader in mobile health IT, cloud-based remote monitoring, health data exchange and analytics solutions. The acquisition expands CRF Health's offerings into the expanding market of wireless medical and wellness devices.
buyer parent:
Vitruvian Partners LLP
buyer: CRF Health
buyer: CRF Health
CRF Health is a leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. CRF Health’s TrialMax eCOA solutions consistently demonstrate the industry’s highest data accuracy, patient and site compliance, and patient retention. "
target:
Entra Health
Entra Health is a mobile health IT company focused on cloud-based remote patient monitoring, telehealth, health data exchange and analytics solutions. They provide technology solutions and services ranging from their own FDA Class II software platform to their one-stop shopping for health devices.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 6/20/2020 via BNC Analysis
TekTone Sound & Signal, acquired Stay Smart Care
synopsis: TekTone has acquired majority ownership in Stay Smart Care, a company whose expertise lies in Remote Patient Monitoring (RPM) solutions. Stay Smart Care offers its solutions for senior living communities, at-home care models, home care agencies and Medicaid/Medicare providers.
buyer:
TekTone Sound & Signal
For over 45 years, TekTone® has designed and manufactured UL® Listed Tek-CARE® nurse call, wireless nurse/emergency call, wander management, Tek-SAFE® area of rescue assistance systems, and Tek-ALERT® integration systems. "
target:
Stay Smart Care
Stay Smart Care is the only senior care solution that provides continuous, non-intrusive healthcare monitoring with smart technology. Stay Smart Care offers Remote Patient Monitoring solutions for senior living communities, at-home care models, home care agencies and Medicaid/Medicare providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 4/19/2019 via BNC Analysis
Activa Capital, acquired Medisys SAS
synopsis: Activa Capital, a leading French mid-market private equity firm, has acquired a majority stake in Medisys, a French software publisher that specializes in the home-care field. Medisys offers management, care, mobility, and remote management software that covers various home healthcare needs.
buyer:
Activa Capital
Activa Capital is a leading French mid-market private equity firm. Activa Capital manages over €500m of private equity funds on behalf of a wide range of institutional investors. Activa Capital partners with ambitious mid-sized French companies, valued at €20m to €200m. "
target:
Medisys SAS
Medisys is a French software publisher that specializes in the home-care field. Medisys offers management, care, mobility, and remote management software that covers various home healthcare needs. Their solutions allow users to monitor their patients in real time, manage health records, and more.
price ($mm)
$56
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 10/17/2018 via BNC Analysis
Waldner Tecnologie Medicali Srl, acquired Nively SAS
synopsis: Waldner Tecnologie Medicali, an Italian company that provides a variety of services to public and private healthcare facilities, has acquired Nively, a French provider of monitoring systems for assisted living facilities. Nively's MentorAge solution is a mobile app that utilizes 3D sensors to allow caregivers to monitor senior citizens.
buyer:
Waldner Tecnologie Medicali Srl
Waldner Tecnologie Medicali is an Italian company that provides a variety of services to public and private healthcare facilities. The company provides services for commercial advice, customer service, installation and testing of whole surgical and medical systems, and more. "
target:
Nively SAS
Nively is a French provider of monitoring systems for assisted living facilities. Their MentorAge solution is a mobile app that utilizes 3D sensors to allow caregivers to monitor senior citizens without invading their privacy. MentorAge provides alerts, internal chat, and resident activity analysis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 2/22/2017 via PR Web
JVION, LLC, purchased Healthcare IT practice from Predixion Software
synopsis: Atlanta-based Jvion, the leading cognitive clinical science machine firm, announced the acquisition of the predictive analytic firm Predixion’s Healthcare IT practice. Atlanta-based Jvion, the leading cognitive clinical science machine firm, announced the acquisition of the predictive analytic firm Predixion’s Healthcare IT practice.
buyer:
JVION, LLC
seller: Predixion Software
Jvion delivers a Cognitive Clinical Success Machine that serves as a high-performance appliance. It activates recommendations that help healthcare providers who need ultra-definition patient-level predictions, prioritizations, interventions, and suggestions. "
seller parent:
GreenWave Systems
seller: Predixion Software
Predixion’s Healthcare IT practice provides predictive analysis to healthcare providers. Predixion has had great success. Most notably, they have helped Carolina’s Health System empower their nursing staff with insights and processes that have led to a reduction in the provider’s readmission rate.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 4/13/2015 via PR Newswire
IBM Watson Health, will acquire Explorys, Inc.
synopsis: IBM announced plans to acquire Explorys, a healthcare intelligence cloud company that has built one of the largest clinical data sets in the world, representing more than 50 million lives. Explorys provides secure cloud-based solutions for clinical integration, at-risk population management, cost of care measurement, and pay-for-performance.
buyer parent:
IBM
buyer: IBM Watson Health
buyer: IBM Watson Health
IBM Watson Health Cloud will bring together clinical, research and social data from a diverse range of health sources, creating a secure, cloud-based data sharing hub, powered by the most advanced cognitive and analytic technologies. "
target:
Explorys, Inc.
Originally inspired by physicians and informatics leaders, Explorys combines the most powerful healthcare computing platform in the world with turnkey solutions for clinical integration, at-risk population management, cost of care measurement, and pay-for-performance solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
Pages:
- buyer to watch list
- seller to watch list
announced 2/19/2021 via PR Newswire
MindMed, will acquire HealthMode
synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer:
MindMed
(OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target:
HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
- buyer to watch list
- seller to watch list
announced 2/19/2021 via PR Newswire
MindMed, will acquire HealthMode
synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer:
MindMed
(OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target:
HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
- buyer to watch list
- seller to watch list
closed 7/16/2009 via PR Newswire
Water Street Healthcare Partners, acquired AAIPharma Services
synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer:
Water Street Healthcare Partners
target: AAIPharma Services
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent:
AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 6/22/2005 via BNC Analysis
Clinical Data, Inc., will acquire Genaissance Pharmaceuticals, Inc.
synopsis: Clinical Data Inc. announced Tuesday that it will acquire Genaissance Pharmaceuticals in an all-stock transaction valued at $56 million. Genaissance shareholders will own 40 percent of the combined company when the deal closes sometime in the fourth quarter.
buyer:
Clinical Data, Inc.
(CLDA:$0.00)
Clinical Data, Inc. provides a full range of products and services to the growing domestic Physician Office Laboratory market and to smaller laboratories internationally & also provides a complete range of products and services for the Physician Office Laboratory and hospital laboratory market. "
target:
Genaissance Pharmaceuticals, Inc.
Genaissance is a world leader in the discovery and use of human gene variation for the development of a new generation of DNA-based diagnostic and therapeutic products. Genaissance markets its technology, clinical development skills and Pharmacogenomic support services to the pharmaceutical industr
price ($mm)
$56
rev ($mm)
$21
EBITDA ($mm)
EV / rev
2.7x
EV / EBITDA
share
watch
bookmark
-
press release
closed 10/26/2010 via Market Wire
Unity Management Group, Inc, acquired Metropolitan Computer Corporation
synopsis: Unity Management Group, Inc announced that it has successfully completed the acquisition of Metropolitan Computer Corporation (MCC/ Legacy).
buyer:
Unity Management Group, Inc
(US:UYMG:$0.00)
Unity Management Group is a health resource company, which provides quality physician practice management services, that offer high value, and significant return, through its three subsidiary companies. United Healthcare Solutions, Unity Technologies Inc., and United Business Services. "
target:
Metropolitan Computer Corporation
Metropolitan Computer Corporation (MCC/ Legacy) designs, engineers, markets, and services instrumentation equipment and software systems for increased efficiency within the pharmaceutical industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 3/6/2012 via PR Newswire
CareFusion Corporation, will acquire PhACTs, LLC.
synopsis: CareFusion Corporation announced an agreement to acquire PHACTS, LLC, a Seattle-based technology and consulting company that helps hospital pharmacies better manage inventory, reduce pharmaceutical costs and streamline operations. Terms of the deal were not disclosed.
buyer:
CareFusion Corporation
(CFN:$3,598.00)
CareFusion Corporation is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. "
target:
PhACTs, LLC.
PHACTS was formed to serve Health Systems with multiple hospitals and/or clinics, doctors' offices, surgery centers and other locations, which need to account for and provide medications and pharmacy supplies across their network.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
announced 8/5/2020 via GlobeNewswire
Livongo will be merged with TelaDoc, Inc.,
synopsis: Teladoc Health, the global leader in virtual care, and Livongo, the leading Applied Health Signals company, have entered into a definitive merger agreement. The combination of Teladoc Health and Livongo will create a global leader in consumer centered virtual care. The combined company will operate under the Teladoc Health brand.
buyer:
TelaDoc, Inc.
(TDOC:$716.29)
Teladoc Health is recognized as the world leader in virtual care. They deliver millions of medical visits across 175 countries annually through the Teladoc Health Medical Group, enabling millions of patient and provider touchpoints for hospitals, health systems, and physician practices globally. "
target:
Livongo
(LVGO:$257.96)
Livongo empowers people with chronic conditions to live better and healthier lives. Using its AI+AI engine, Livongo aggregates and interprets health data and information to create actionable, personalized, and timely health signals delivered to Livongo Members exactly when and where they need them.
price ($mm)[EV]
$16,988 [$16,567]
rev ($mm)
$258
EBITDA ($mm)
EV / rev
70.8x
EV / EBITDA
share
watch
bookmark
-
press release
announced 6/3/2020 via BusinessWire
BreathResearch will be merged with AireHealth,
synopsis: AireHealth Inc., a company that offers affordable treatments, symptom tracking and early detection of respiratory conditions, has reached a merger agreement with BreathResearch, a respiratory healthcare company that detects increasing declines in respiratory health status.
buyer:
AireHealth
AireHealth offers affordable treatments, symptom tracking and early detection of respiratory conditions. The company provides monitored drug delivery via its FDA cleared Class 2 portable nebulizer, designed to deliver medicine directly to a patient’s lungs where it is most effective. "
target:
BreathResearch
BreathResearch is an innovative healthcare company that offers a solution that converts the air waves from breathing into sound waves producing new respiratory analytics to improve health, fitness and performance.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 11/14/2018 via BNC Analysis
MindMaze, acquired Neuro Motor Innovations Corporation
synopsis: MindMaze, operator of a platform that captures brain activity announced its acquisition of fellow neuro-rehabilitation tech company Neuro Motor Innovations Corporation (NMI). NMI is a medical technology company with a mission to improve movement and cognition outcomes through their brain repair therapy.
buyer:
MindMaze
MindMaze operates a platform that captures brain activity, creating a new operating system for computers - a brain O/S. They designed an intuitive mind/machine interface, which utilizes pre-realtime decoding of brain signals via neural prediction, transforming healthcare and gaming industries. "
target:
Neuro Motor Innovations Corporation
Neuro Motor Innovations (NMI) is a medical technology company with a mission to improve movement and cognition outcomes in aging and neurology patients. NMI’s solution includes a proprietary medical gaming platform, game therapy software, and hardware control devices for hand, arm, foot and face.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 12/1/2016 via GlobeNewswire
BioTelemetry, acquired Telcare
synopsis: BioTelemetry, Inc. is pleased to announce the acquisition of Telcare. Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
buyer:
BioTelemetry
(BEAT:$386.46)
BioTelemetry, Inc. is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The company currently provides cardiac monitoring services, original equipment manufacturing and more. "
target:
Telcare
Telcare is a leading digital-health company whose pioneering work includes development of the first FDA-cleared cellular enabled blood glucometer and cloud-based diabetes data repository system.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 6/6/2012 via BusinessWire
MeadWestvaco Corporation, acquired AARDEX Group SA
synopsis: MeadWestvaco Corporation announced that it is expanding its leading position in adherence packaging with the acquisition of AARDEX Group SA. AARDEX is the leader and pioneer in the design and use of electronic medication event monitoring systems and applications designed to measure, analyze, and manage patient adherence in clinical drug trials.
buyer:
MeadWestvaco Corporation
(WRK:$6,049.00)
MeadWestvaco Corporation provides packaging solutions to many of the world’s most-admired brands in the healthcare, beauty and personal care, food, beverage, home and garden, and tobacco industries. "
target:
AARDEX Group SA
AARDEX Group is the pioneer and world leader in developing, manufacturing, and marketing MEMS™, Medication Event Monitoring System, which measures, analyzes and facilitates patients' adherence to prescribed drug dosing regimens in clinical trials.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
share
watch
bookmark
-
press release
closed 8/2/2004 via BusinessWire
Apogent Technologies, Inc. merged with Fisher Scientific International Inc.,
synopsis: Fisher Scientific International Inc. (NYSE: FSH) today completed its approximately $4.0 billion merger with Apogent Technologies Inc. (formerly trading as NYSE: AOT), providing Fisher Scientific with a $1.1 billion footprint in the high-growth life-science market.
buyer parent:
Thomas H. Lee Partners, L.P.
buyer: Fisher Scientific International Inc.
buyer: Fisher Scientific International Inc.
Fisher Scientific International, Inc. provides products and services to the scientific research and clinical laboratory markets. It operates in three segments: Scientific Products and Services, Healthcare Products and Services, and Laboratory Workstations. The Scientific Products and Services segmen"
target:
Apogent Technologies, Inc.
Apogent Technologies Inc. is a developer and manufacturer of value-added products for the clinical and research markets. Over 80% of the Company's products are consumables. Apogent's operating subsidiaries manufacture most of their products in approximately 80 facilities worldwide. The Company's cu
price ($mm)
$3,991
rev ($mm)
$1,118
EBITDA ($mm)
$313
EV / rev
3.6x
EV / EBITDA
12.7x
share
watch
bookmark
-
press release
Like HealthMode
read more
Pages:
read more
read more
read more
Geography
Matching Companies
Ticker: CNSX:PHGI
Premier Health Group Inc.
year
2020
rev ($mm)
$9.18
EBITDA ($mm)
($6.28)
EBIT ($mm)
($6.31)
Net Income ($mm)
Employees
0
drill down
watch
Ticker: INOV
Inovalon, Inc.
year
2017
rev ($mm)
$449.36
EBITDA ($mm)
$75.91
EBIT ($mm)
$27.16
Net Income ($mm)
$34.82
Employees
2119
drill down
watch
Ticker: TSXV:MSD
Moseda Technologies, Inc.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
drill down
watch
Ticker: OTCPK:HNSS
Healthnostics, Inc.
year
2012
rev ($mm)
$0.20
EBITDA ($mm)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
drill down
watch
Ticker: OTCPK:IGMB.D
Clinigence, LLC.
year
2018
rev ($mm)
$1.37
EBITDA ($mm)
($0.84)
EBIT ($mm)
($0.84)
Net Income ($mm)
Employees
0
drill down
watch
Ticker: ASX:PKS
Pacific Knowledge Systems
year
2019
rev ($mm)
$1.38
EBITDA ($mm)
($0.20)
EBIT ($mm)
($0.18)
Net Income ($mm)
Employees
0
drill down
watch
Ticker: ASX:VHT
Volpara Solutions
year
2019
rev ($mm)
$3.29
EBITDA ($mm)
($7.96)
EBIT ($mm)
($8.08)
Net Income ($mm)
Employees
53
drill down
watch
Ticker: OM:RTC
Rethinking Care AB
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
drill down
watch
Ticker: OTCQB: EHVVF
Ehave, Inc.
year
2018
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($0.76)
Net Income ($mm)
Employees
0
drill down
watch
Ticker: CM:CLRX
CollabRX, Inc
year
2014
rev ($mm)
$0.38
EBITDA ($mm)
($4.07)
EBIT ($mm)
($4.32)
Net Income ($mm)
Employees
1
drill down
watch
Ticker: TSXV:CRBK
Carebook Technologies Inc.
year
2020
rev ($mm)
$2.87
EBITDA ($mm)
($4.24)
EBIT ($mm)
($4.44)
Net Income ($mm)
Employees
38
drill down
watch
Ticker: DB:COP
CompuGroup Medical AG
year
2019
rev ($mm)
$879.35
EBITDA ($mm)
$200.48
EBIT ($mm)
$134.28
Net Income ($mm)
$82.69
Employees
5171
drill down
watch
Ticker: AIM:EMIS
EMIS Group PLC
year
2018
rev ($mm)
$216.76
EBITDA ($mm)
$33.15
EBIT ($mm)
$21.39
Net Income ($mm)
$14.24
Employees
2046
drill down
watch
Ticker: EVH
Evolent Health
year
2016
rev ($mm)
$212.24
EBITDA ($mm)
($39.30)
EBIT ($mm)
($52.25)
Net Income ($mm)
Employees
946
drill down
watch
Ticker: TRHC
Tabula Rasa Healthcare
year
2018
rev ($mm)
$204.27
EBITDA ($mm)
$16.27
EBIT ($mm)
$1.63
Net Income ($mm)
Employees
952
drill down
watch
Ticker: MRK
Merck & Co., Inc.
year
2020
rev ($mm)
$48,081.00
EBITDA ($mm)
$19,058.00
EBIT ($mm)
$15,735.00
Net Income ($mm)
$10,147.00
Employees
71000
drill down
watch
Ticker: OTCPK:MMED.F
MindMed
year
2020
rev ($mm)
EBITDA ($mm)
($24.86)
EBIT ($mm)
($25.61)
Net Income ($mm)
Employees
0
drill down
watch
Ticker: ASX:AVX
Avexa Limited
year
2015
rev ($mm)
$0.24
EBITDA ($mm)
($1.45)
EBIT ($mm)
($1.46)
Net Income ($mm)
Employees
5
drill down
watch
Ticker: COV
Covidien
year
2010
rev ($mm)
$10,429.00
EBITDA ($mm)
$2,628.00
EBIT ($mm)
$2,139.00
Net Income ($mm)
$1,632.00
Employees
41500
drill down
watch
Ticker: JNJ
Johnson & Johnson
year
2019
rev ($mm)
$81,325.00
EBITDA ($mm)
$27,998.00
EBIT ($mm)
$21,066.00
Net Income ($mm)
$16,332.00
Employees
135100
drill down
watch
Ticker: CAH
Cardinal Health, Inc.
year
2018
rev ($mm)
$141,935.00
EBITDA ($mm)
$2,870.00
EBIT ($mm)
$1,860.00
Net Income ($mm)
Employees
50200
drill down
watch
Ticker: BDX
Becton, Dickinson and Company
year
2020
rev ($mm)
$17,117.00
EBITDA ($mm)
$4,569.00
EBIT ($mm)
$2,415.00
Net Income ($mm)
$874.00
Employees
65000
drill down
watch
Ticker: FMS
Fresenius Medical Care AG & Co. KGaA
year
2009
rev ($mm)
$11,247.48
EBITDA ($mm)
$2,212.68
EBIT ($mm)
$1,755.60
Net Income ($mm)
$891.14
Employees
72812
drill down
watch
Ticker: FAGR
Fagron
year
2014
rev ($mm)
$473.30
EBITDA ($mm)
$113.50
EBIT ($mm)
$96.32
Net Income ($mm)
$17.17
Employees
1902
drill down
watch
Ticker: RMD
ResMed
year
2019
rev ($mm)
$2,784.41
EBITDA ($mm)
$858.38
EBIT ($mm)
$696.96
Net Income ($mm)
$454.92
Employees
7240
drill down
watch
Ticker: LVGO
Livongo
year
2020
rev ($mm)
$257.96
EBITDA ($mm)
($35.05)
EBIT ($mm)
($38.15)
Net Income ($mm)
Employees
615
drill down
watch
Ticker: NMRD
Nemaura Medical, Inc.
year
2020
rev ($mm)
EBITDA ($mm)
($4.72)
EBIT ($mm)
($4.78)
Net Income ($mm)
Employees
17
drill down
watch
Ticker: ABT
Abbott Laboratories
year
2009
rev ($mm)
$30,764.71
EBITDA ($mm)
$8,220.25
EBIT ($mm)
$6,130.74
Net Income ($mm)
$5,745.84
Employees
73000
drill down
watch
Ticker: SYK
Stryker Corporation
year
2016
rev ($mm)
$10,062.00
EBITDA ($mm)
$2,717.00
EBIT ($mm)
$2,312.00
Net Income ($mm)
$1,617.00
Employees
27000
drill down
watch
Ticker: HOLX
Hologic, Inc.
year
2011
rev ($mm)
$1,789.35
EBITDA ($mm)
$595.38
EBIT ($mm)
$290.64
Net Income ($mm)
$157.15
Employees
5019
drill down
watch